154 related articles for article (PubMed ID: 21756164)
1. Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk.
Onat A; Hergenç G; Can G; Uğur M; Nartop F
Clin Chem Lab Med; 2011 Aug; 49(8):1349-1357. PubMed ID: 21756164
[TBL] [Abstract][Full Text] [Related]
2. [Impact of gender on lipoprotein-associated phospholipase A2 activity and association with known cardiovascularrisk factors].
Jia ZR; Zhao D; Qi Y; Wang W; Wang M; Sun JY; Qin LP; Liu J
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Nov; 41(11):962-7. PubMed ID: 24370228
[TBL] [Abstract][Full Text] [Related]
3. Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study.
Tselepis AD; Panagiotakos DB; Pitsavos C; Tellis CC; Chrysohoou C; Stefanadis C
Atherosclerosis; 2009 Sep; 206(1):303-8. PubMed ID: 19394616
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A₂ mass in type 2 diabetes mellitus: relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity.
Constantinides A; de Vries R; van Leeuwen JJ; Gautier T; van Pelt LJ; Tselepis AD; Lagrost L; Dullaart RP
Eur J Intern Med; 2012 Oct; 23(7):633-8. PubMed ID: 22902096
[TBL] [Abstract][Full Text] [Related]
5. The role of lipoprotein-associated phospholipase A(2) in the metabolic syndrome and diabetes.
Noto H; Chitkara P; Raskin P
J Diabetes Complications; 2006; 20(6):343-8. PubMed ID: 17070436
[TBL] [Abstract][Full Text] [Related]
6. Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literature.
Gregson J; Stirnadel-Farrant HA; Doobaree IU; Koro C
Atherosclerosis; 2012 Nov; 225(1):11-21. PubMed ID: 22784637
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.
Nelson TL; Biggs ML; Kizer JR; Cushman M; Hokanson JE; Furberg CD; Mukamal KJ
J Clin Endocrinol Metab; 2012 May; 97(5):1695-701. PubMed ID: 22399516
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
[TBL] [Abstract][Full Text] [Related]
9. Association of lipoprotein-associated phospholipase A₂ activity with components of the metabolic syndrome in apparently healthy boys.
Hirschler V; Meroño T; Maccallini G; Gomez Rosso L; Aranda C; Brites F
Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):78-83. PubMed ID: 21476960
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) bound to LDL and HDL.
Tellis CC; Tselepis AD
Curr Pharm Des; 2014; 20(40):6256-69. PubMed ID: 24953389
[TBL] [Abstract][Full Text] [Related]
12. Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study.
Furberg CD; Nelson JJ; Solomon C; Cushman M; Jenny NS; Psaty BM
J Am Geriatr Soc; 2008 May; 56(5):792-9. PubMed ID: 18363676
[TBL] [Abstract][Full Text] [Related]
13. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.
Constantinides A; Kappelle PJ; Lambert G; Dullaart RP
Arch Med Res; 2012 Jan; 43(1):11-4. PubMed ID: 22300679
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.
Nelson TL; Kamineni A; Psaty B; Cushman M; Jenny NS; Hokanson J; Furberg C; Mukamal KJ
Diabetologia; 2011 Feb; 54(2):329-33. PubMed ID: 21103980
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.
Gazi I; Lourida ES; Filippatos T; Tsimihodimos V; Elisaf M; Tselepis AD
Clin Chem; 2005 Dec; 51(12):2264-73. PubMed ID: 16223884
[TBL] [Abstract][Full Text] [Related]
17. Serum apolipoprotein C-III in high-density lipoprotein: a key diabetogenic risk factor in Turks.
Onat A; Hergenç G; Ayhan E; Uğur M; Kaya H; Tuncer M; Can G
Diabet Med; 2009 Oct; 26(10):981-8. PubMed ID: 19900229
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes.
Hatoum IJ; Hu FB; Nelson JJ; Rimm EB
Diabetes; 2010 May; 59(5):1239-43. PubMed ID: 20185811
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of lipoprotein-associated phospholipase A(2) are increased in patients with β-thalassemia.
Tselepis AD; Hahalis G; Tellis CC; Papavasiliou EC; Mylona PT; Kourakli A; Alexopoulos DC
J Lipid Res; 2010 Nov; 51(11):3331-41. PubMed ID: 20625038
[TBL] [Abstract][Full Text] [Related]
20. Combining rosuvastatin with sartans of different peroxisome proliferator-activated receptor-γ activating capacity is not associated with different changes in low-density lipoprotein subfractions and plasma lipoprotein-associated phospholipase A₂.
Rizos CV; Liberopoulos EN; Tellis CC; Florentin M; Elisaf MS; Tselepis AD
Metab Syndr Relat Disord; 2011 Jun; 9(3):217-23. PubMed ID: 21352079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
